BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37229950)

  • 1. Visualization research on ENT1/NIS dual-function gene therapy to reverse drug resistance mediated by MUC1 in GEM-resistant pancreatic cancer.
    Xi Y; Chen H; Xi Y; Hai W; Qu Q; Zhang M; Li B
    Nucl Med Biol; 2023; 120-121():108350. PubMed ID: 37229950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model.
    Paproski RJ; Wuest M; Jans HS; Graham K; Gati WP; McQuarrie S; McEwan A; Mercer J; Young JD; Cass CE
    J Nucl Med; 2010 Sep; 51(9):1447-55. PubMed ID: 20720035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of 18F-FLT uptake with equilibrative nucleoside transporter-1 and thymidine kinase-1 expressions in gastrointestinal cancer.
    Kameyama R; Yamamoto Y; Izuishi K; Sano T; Nishiyama Y
    Nucl Med Commun; 2011 Jun; 32(6):460-5. PubMed ID: 21423062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
    Liu M; Zhang Y; Yang J; Cui X; Zhou Z; Zhan H; Ding K; Tian X; Yang Z; Fung KA; Edil BH; Postier RG; Bronze MS; Fernandez-Zapico ME; Stemmler MP; Brabletz T; Li YP; Houchen CW; Li M
    Gastroenterology; 2020 Feb; 158(3):679-692.e1. PubMed ID: 31711924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer.
    Lee SJ; Yeo JS; Lee HJ; Lee EJ; Kim SY; Jang SJ; Lee JJ; Ryu JS; Moon DH
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1327-35. PubMed ID: 24562648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide increases equilibrative nucleoside transporter 1 activity and fluorothymidine uptake: screening of 60 cytotoxic agents.
    Lee EJ; Lee SJ
    Oncol Rep; 2013 Feb; 29(2):763-70. PubMed ID: 23232555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3'-Deoxy-3'-[(18)F]-fluorothymidine ([(18)F]-FLT) transport in newly diagnosed glioma: correlation with nucleoside transporter expression, vascularization, and blood-brain barrier permeability.
    Shinomiya A; Miyake K; Okada M; Nakamura T; Kawai N; Kushida Y; Haba R; Kudomi N; Tokuda M; Tamiya T
    Brain Tumor Pathol; 2013 Oct; 30(4):215-23. PubMed ID: 23423309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of human equilibrative nucleoside transporter-1 are higher in proliferating regions of A549 tumor cells grown as tumor xenografts in vivo.
    Plotnik DA; Asher C; Chu SK; Miyaoka RS; Garwin GG; Johnson BW; Li T; Krohn KA; Schwartz JL
    Nucl Med Biol; 2012 Nov; 39(8):1161-6. PubMed ID: 22985987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hENT1 reverses chemoresistance by regulating glycolysis in pancreatic cancer.
    Xi Y; Yuan P; Li T; Zhang M; Liu MF; Li B
    Cancer Lett; 2020 Jun; 479():112-122. PubMed ID: 32200037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin and its cyclohexanone analogue inhibited human Equilibrative nucleoside transporter 1 (ENT1) in pancreatic cancer cells.
    Revalde JL; Li Y; Wijeratne TS; Bugde P; Hawkins BC; Rosengren RJ; Paxton JW
    Eur J Pharmacol; 2017 May; 803():167-173. PubMed ID: 28365185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hypoxia on human equilibrative nucleoside transporters hENT1 and hENT2 in breast cancer.
    Krys D; Hamann I; Wuest M; Wuest F
    FASEB J; 2019 Dec; 33(12):13837-13851. PubMed ID: 31601121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3'-Deoxy-3'-¹⁸F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer.
    Challapalli A; Barwick T; Pearson RA; Merchant S; Mauri F; Howell EC; Sumpter K; Maxwell RJ; Aboagye EO; Sharma R
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):831-40. PubMed ID: 25673055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1.
    Hu Q; Qin Y; Zhang B; Liang C; Ji S; Shi S; Xu W; Xiang J; Liang D; Ni Q; Yu X; Xu J
    Oncol Rep; 2017 Oct; 38(4):2069-2077. PubMed ID: 28765935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3'-deoxy-3'-fluorothymidine.
    Paproski RJ; Young JD; Cass CE
    Biochem Pharmacol; 2010 Feb; 79(4):587-95. PubMed ID: 19788890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells.
    Hioki M; Shimada T; Yuan T; Nakanishi T; Tajima H; Yamazaki M; Yokono R; Takabayashi M; Sawamoto K; Akashita G; Miyamoto KI; Ohta T; Tamai I; Shimada T; Sai Y
    Biopharm Drug Dispos; 2018 May; 39(5):256-264. PubMed ID: 29682747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of thymidine kinase 1 after 5-fluorouracil as a mechanism for 3'-deoxy-3'-[18F]fluorothymidine flare.
    Lee SJ; Kim SY; Chung JH; Oh SJ; Ryu JS; Hong YS; Kim TW; Moon DH
    Biochem Pharmacol; 2010 Nov; 80(10):1528-36. PubMed ID: 20723540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMT-Induced Gemcitabine Resistance in Pancreatic Cancer Involves the Functional Loss of Equilibrative Nucleoside Transporter 1.
    Weadick B; Nayak D; Persaud AK; Hung SW; Raj R; Campbell MJ; Chen W; Li J; Williams TM; Govindarajan R
    Mol Cancer Ther; 2021 Feb; 20(2):410-422. PubMed ID: 33298588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-expression profiling reveals down-regulation of equilibrative nucleoside transporter 1 (ENT1) in Ara-C-resistant CCRF-CEM-derived cells.
    Takagaki K; Katsuma S; Kaminishi Y; Horio T; Nakagawa S; Tanaka T; Ohgi T; Yano J
    J Biochem; 2004 Nov; 136(5):733-40. PubMed ID: 15632314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung.
    Ashek A; Spruijt OA; Harms HJ; Lammertsma AA; Cupitt J; Dubois O; Wharton J; Dabral S; Pullamsetti SS; Huisman MC; Frings V; Boellaard R; de Man FS; Botros L; Jansen S; Vonk Noordegraaf A; Wilkins MR; Bogaard HJ; Zhao L
    Circ Cardiovasc Imaging; 2018 Aug; 11(8):e007402. PubMed ID: 30354494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nucleoside/nucleotide transport and metabolism in the uptake and retention of 3'-fluoro-3'-deoxythymidine in human B-lymphoblast cells.
    Plotnik DA; McLaughlin LJ; Chan J; Redmayne-Titley JN; Schwartz JL
    Nucl Med Biol; 2011 Oct; 38(7):979-86. PubMed ID: 21982569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.